Alnylam Pharmaceuticals (ALNY) Asset Utilization Ratio (2009 - 2026)
Alnylam Pharmaceuticals' Asset Utilization Ratio was 0.74 in Q3 2026, up 11.8% from 0.66 a year earlier but down 17.7% from the prior quarter.
Powered by 
Analysis
Alnylam Pharmaceuticals (ALNY) Asset Utilization Ratio (2009 - 2026) Analysis & Trends
For FY2025, Asset Utilization Ratio at Alnylam Pharmaceuticals came in at 0.81, up 44.8% from FY2024.
- Asset Utilization Ratio has now increased for seven consecutive years.
- In earlier years, Asset Utilization Ratio was 0.56 in FY2024 (+12.4%), 0.50 in FY2023 (+71.8%), 0.29 in FY2022 (+20.5%) and 0.24 in FY2021 (+41.0%).
- Quarterly Asset Utilization Ratio has moved between 0.24 (Q4 2021) and 0.90 (Q2 2026) over five years.
- Compared with a year earlier, Asset Utilization Ratio was higher in five of the last six quarters, with growth averaging 24.6%.
- The best year-over-year quarter for Asset Utilization Ratio over five years was Q3 2023 (growth of 70.1%); the worst was Q2 2025 (a decline of 3.8%).
- Per Business Quant data, ALNY's Asset Utilization Ratio in the three quarters before Q3 2026 was 0.90 (Q2 2026), 0.85 (Q1 2026) and 0.76 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 0.60 |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 0.50 |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 0.47 |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 0.51 |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 0.50 |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 0.41 |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 0.62 |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 0.31 |
| 10 | Alnylam Pharmaceuticals | 20.30 Bn | 7.49 Bn | 1.10 Bn | 0.74 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 0.74 |
| Jun 30, 2026 | 0.90 |
| Mar 31, 2026 | 0.85 |
| Dec 31, 2025 | 0.76 |
| Sep 30, 2025 | 0.66 |
| Jun 30, 2025 | 0.58 |
| Dec 31, 2024 | 0.53 |
| Sep 30, 2024 | 0.51 |
| Jun 30, 2024 | 0.60 |
| Mar 31, 2024 | 0.52 |
| Dec 31, 2023 | 0.48 |
| Sep 30, 2023 | 0.48 |
| Jun 30, 2023 | 0.36 |
| Mar 31, 2023 | 0.33 |
| Dec 31, 2022 | 0.29 |
| Sep 30, 2022 | 0.28 |
| Jun 30, 2022 | 0.26 |
| Mar 31, 2022 | 0.25 |
| Dec 31, 2021 | 0.24 |
| Sep 30, 2021 | 0.21 |
API Access
Alnylam Pharmaceuticals Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=ALNY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "ALNY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=ALNY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();